Use of Intraoperative Radiotherapy in Pancreatic Cancer After Neoadjuvant Chemoradiotherapy: First National Application
PDF
Cite
Share
Request
Case Report
P: 127-130
December 2016

Use of Intraoperative Radiotherapy in Pancreatic Cancer After Neoadjuvant Chemoradiotherapy: First National Application

Bezmialem Science 2016;4(3):127-130
1. Clinic of General Surgery, Okmeydanı Training and Research Hospital, İstanbul, Turkey
2. Clinic of Radiation Oncology, Okmeydanı Training and Research Hospital, İstanbul, Turkey
No information available.
No information available
Received Date: 27.12.2015
Accepted Date: 15.02.2016
PDF
Cite
Share
Request

ABSTRACT

Intraoperative radiotherapy (IORT) is a single fractional procedure performed during surgery in patients with pancreatic cancer. Its usage will increase in the future, particularly in abdominal disorders such as pancreatic cancer, in which prognostic outcomes are still poor despite technical improvements in radiotherapy and new drugs in chemotherapy. In this paper, we reported the case of a patient with pancreatic carcinoma localized in the junction of the head and body of the pancreas. After preoperative chemoradiotherapy (45 Gy radiotherapy with gemcitabine), distal pancreatectomy and splenectomy were performed and 12.5 Gy IORT was administered. The postoperative course was uneventful, except for a wound infection that was conservatively treated. A pathologic examination revealed resection of adenocarcinoma with negative surgical borders. The aim of this case report was to present the first IORT application for pancreatic cancer in Turkey. IORT can be used to decrease the possibility of microscopic residual disease in pancreatic tumors.

Keywords: Intraoperative radiotherapy, pancreatic carcinoma, gemcitabine

References

2024 ©️ Galenos Publishing House